Display options
Share it on

Intern Emerg Med. 2021 Feb 26; doi: 10.1007/s11739-021-02668-1. Epub 2021 Feb 26.

Poor outcome among patients undergoing myocardial perfusion imaging with intermediate-zone troponin.

Internal and emergency medicine

Anat Berkovitch, Alexey Naimushin, Nir Shlomo, Shlomi Matetzky, Roy Beigel, Michael Naroditsky, Elad Asher, Eli Rozen, Ilan Goldenberg, Robert Klempfner, Ronen Goldkorn

Affiliations

  1. Division of Cardiology, Leviev Heart and Vascular Center, Chaim Sheba Medical Center, 52621, Tel Hashomer, Israel. [email protected].
  2. Sackler School of Medicine, Tel-Aviv University, Tel Aviv, Israel. [email protected].
  3. Division of Cardiology, Leviev Heart and Vascular Center, Chaim Sheba Medical Center, 52621, Tel Hashomer, Israel.
  4. Sackler School of Medicine, Tel-Aviv University, Tel Aviv, Israel.
  5. Shaare Zedek Medical Center, Affiliated with the Hadassah-Hebrew University Medical School, Jerusalem, Israel.
  6. The University of Rochester Medical Center, New York, NY, USA.

PMID: 33638094 DOI: 10.1007/s11739-021-02668-1

Abstract

BACKGROUND: Intermediate zone troponin elevation is defined as one to five times the upper limit of normal. Approximately half the patients presenting with chest pain to the emergency department have initial intermediate zone troponin.

OBJECTIVES: We aimed to investigate the long-term outcome of patients hospitalized with chest pain and intermediate zone troponin elevation.

METHODS: We investigated 8269 patients hospitalized in a tertiary center with chest pain. All patients had serial measurements of troponin during hospitalization. Patients were divided into three groups based on their initial troponin levels: negative troponin (N = 6112), intermediate zone troponin (N = 1329) and positive troponin (N = 828). All patients underwent myocardial perfusion imaging (MPI) as part of the initial evaluation.

RESULTS: Mean age of the study population was 68 ± 11, of whom 36% were women. Patients with an intermediate zone troponin were older, more likely to be males, and with significantly more cardiovascular co-morbidities. Multivariate analysis adjusted for age, gender, cardiovascular risk factors, and abnormal MPI result found that patients with intermediate zone troponin had a 70% increased risk of re-hospitalization at 1 year (HR 1.70, 95%CI 1.48-1.96, p-value < 0.001) and 5.3 times higher risk of total mortality at 1-year (HR 5.33, 95%CI 3.65-7.78, p-value < 0.001). sub-group analysis found that among the intermediate zone troponin group, patients with double intermediate zone troponin had the poorest outcome.

CONCLUSIONS: Intermediate zone troponin elevation is an independent risk factor associated with adverse outcomes and therefore patients with an initial value in this range should be closely monitored and aggressively managed.

Keywords: Acute coronary syndrome; Chest pain; Myocardial perfusion imaging; Troponin

References

  1. Lee HM, Kerr D, Ici OHD, Kelly A-M (2010) Clinical significance of initial troponin I in the grey zone in emergency department chest pain patients: a retrospective pilot study. Emerg Med J EMJ. 27:302–304 - PubMed
  2. Mehta S, Bautista RM, Adams BD (2009) Role of first-drawn indeterminate troponin-I levels in the Emergency Department. Int J Cardiol 134:417–418 - PubMed
  3. Jeremias A, Gibson CM (2005) Narrative review: alternative causes for elevated cardiac troponin levels when acute coronary syndromes are excluded. Ann Intern Med 142:786–791 - PubMed
  4. Waxman DA, Hecht S, Schappert J, Husk G (2006) A model for troponin I as a quantitative predictor of in-hospital mortality. J Am Coll Cardiol 48:1755–1762 - PubMed
  5. Halim SA, Mulgund J, Chen AY, Roe MT, Peterson ED, Gibler WB, Ohman EM, Newby LK (2009) Use of guidelines-recommended management and outcomes among women and men with low-level troponin elevation: Insights From CRUSADE. Circ Cardiovasc Qual Outcomes 2:199–206 - PubMed
  6. Wu AHB, Jaffe AS (2008) The clinical need for high-sensitivity cardiac troponin assays for acute coronary syndromes and the role for serial testing. Am Heart J 155:208–214 - PubMed
  7. Abbott BG, Jain D (2003) Impact of myocardial perfusion imaging on clinical management and the utilization of hospital resources in suspected acute coronary syndromes. Nucl Med Commun - PubMed
  8. Cremer PC, Khalaf S, Agarwal S, Mayer-Sabik E, Ellis SG, Menon V, Cerqueira MD, Jaber WA (2014) Myocardial perfusion imaging in emergency department patients with negative cardiac biomarkers yield for detecting ischemia, short-term events, and impact of downstream revascularization on mortality. Circ Cardiovasc Imaging - PubMed
  9. Ahmed W, Schlett CL, Uthamalingam S, Truong QA, Koenig W, Rogers IS, Blankstein R, Nagurney JT, Tawakol A, Januzzi JL, Hoffmann U (2013) Single resting hsTnT level predicts abnormal myocardial stress test in acute chest pain patients with normal initial standard troponin. JACC Cardiovasc Imaging - PubMed
  10. Kontos MC, Shah R, Fritz LM, Anderson FP, Tatum JL, Ornato JP, Jesse RL (2004) Implication of different cardiac troponin I levels for clinical outcomes and prognosis of acute chest pain patients. J Am Coll Cardiol 43:958–965 - PubMed
  11. Ndrepepa G, Braun S, Mehilli J, Birkmeier KA, Byrne RA, Ott I, Hösl K, Schulz S, Fusaro M, Pache J, Hausleiter J, Laugwitz KL, Massberg S, Seyfarth M, Schömig A, Kastrati A (2011) Prognostic value of sensitive troponin T in patients with stable and unstable angina and undetectable conventional troponin. Am Heart J 161:68–75 - PubMed
  12. Lindahl B, Venge P, Wallentin L (1996) Relation between Troponin T and the risk of subsequent cardiac events in unstable coronary artery disease. Circulation 93:1651–1657 - PubMed
  13. Zethelius B, Johnston N, Venge P (2006) Troponin I as a predictor of coronary heart disease and mortality in 70-year-old men: a community-based cohort study. Circulation 113:1071–1078 - PubMed
  14. Verani MS, Jeroudi MO, Mahmarian JJ, Boyce TM, Borges-Neto S, Patel B, Bolli R (1988) Quantification of myocardial infarction during coronary occlusion and myocardial salvage after reperfusion using cardiac imaging with technetium-99m hexakis 2-methoxyisobutyl isonitrile. J Am Coll Cardiol 12:1573–1581 - PubMed
  15. Thygesen K, Alpert JS, Jaffe AS, Chaitman BR, Bax JJ, Morrow DA, White HD, Mickley H, Crea F, Van De Werf F, Bucciarelli-Ducci C, Katus HA, Pinto FJ, Antman EM, Hamm CW, De Caterina R, Januzzi JL, Apple FS, Garcia MAA, Underwood SR, Canty JM, Lyon AR, Devereaux PJ, Zamorano JL, Lindahl B, Weintraub WS, Newby LK, Virmani R, Vranckx P, Cutlip D, Gibbons RJ, Smith SC, Atar D, Luepker RV, Robertson RM, Bonow RO, Steg PG, O’Gara PT, Fox KAA, Hasdai D, Aboyans V, Achenbach S, Agewall S, Alexander T, Avezum A, Barbato E, Bassand JP, Bates E, Bittl JA, Breithardt G, Bueno H, Bugiardini R, Cohen MG, Dangas G, De Lemos JA, Delgado V, Filippatos G, Fry E, Granger CB, Halvorsen S, Hlatky MA, Ibanez B, James S, Kastrati A, Leclercq C, Mahaffey KW, Mehta L, Müller C, Patrono C, Piepoli MF, Piñeiro D, Roffi M, Rubboli A, Sharma S, Simpson IA, Tendera M, Valgimigli M, Van Der Wal AC, Windecker S (2019) Fourth universal definition of myocardial infarction (2018). Eur Heart J - PubMed
  16. Neumann FJ, Sechtem U, Banning AP, Bonaros N, Bueno H, Bugiardini R, Chieffo A, Crea F, Czerny M, Delgado V, Dendale P, Knuuti J, Wijns W, Flachskampf FA, Gohlke H, Grove EL, James S, Katritsis D, Landmesser U, Lettino M, Matter CM, Nathoe H, Niessner A, Patrono C, Petronio AS, Pettersen SE, Piccolo R, Piepoli MF, Popescu BA, Räber L, Richter DJ, Roffi M, Roithinger FX, Shlyakhto E, Sibbing D, Silber S, Simpson IA, Sousa-Uva M, Vardas P, Witkowski A, Zamorano JL, Achenbach S, Agewall S, Barbato E, Bax JJ, Capodanno D, Cuisset T, Deaton C, Dickstein K, Edvardsen T, Escaned J, Funck-Brentano C, Gersh BJ, Gilard M, Hasdai D, Hatala R, Mahfoud F, Masip J, Muneretto C, Prescott E, Saraste A, Storey RF, Svitil P, Valgimigli M, Aboyans V, Baigent C, Collet JP, Dean V, Fitzsimons D, Gale CP, Grobbee DE, Halvorsen S, Hindricks G, Iung B, Jüni P, Katus HA, Leclercq C, Lewis BS, Merkely B, Mueller C, Petersen S, Touyz RM, Benkhedda S, Metzler B, Sujayeva V, Cosyns B, Kusljugic Z, Velchev V, Panayi G, Kala P, Haahr-Pedersen SA, Kabil H, Ainla T, Kaukonen T, Cayla G, Pagava Z, Woehrle J, Kanakakis J, Toth K, Gudnason T, Peace A, Aronson D, Riccio C, Elezi S, Mirrakhimov E, Hansone S, Sarkis A, Babarskiene R, Beissel J, Cassar Maempel AJ, Revenco V, de Grooth GJ, Pejkov H, Juliebø V, Lipiec P, Santos J, Chioncel O, Duplyakov D, Bertelli L, Dikic AD, Studencan M, Bunc M, Alfonso F, Back M, Zellweger M, Addad F, Yildirir A, Sirenko Y, Clapp B (2020) 2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes. Eur Heart J 41:407–477 - PubMed
  17. Takx RAP, Blomberg BA, Aidi H El, Habets J, De Jong PA, Nagel E, Hoffmann U, Leiner T (2014) Diagnostic accuracy of stress myocardial perfusion imaging compared to invasive coronary angiography with fractional flow reserve meta-analysis. Circ Cardiovasc Imaging 8 - PubMed
  18. Schwartz JG, Johnson RB, Aepfelbacher FC, Parker JA, Chen L, Azar RR, Parker RA, Danias PG (2003) Sensitivity, specificity and accuracy of stress spect myocardial perfusion imaging for detection of coronary artery disease in the distribution of first-order branch vessels, using an anatomical matching of angiographic and perfusion data. Nucl Med Commun 24:543–549 - PubMed
  19. Karthikeyan G, Guzic Salobir B, Jug B, Devasenapathy N, Alexanderson E, Vitola J, Kraft O, Ozkan E, Sharma S, Purohit G, Dolenc Novak M, Meave A, Trevethan S, Cerci R, Zier S, Gotthardtová L, Jonszta T, Altin T, Soydal C, Patel C, Gulati G, Paez D, Dondi M, Kashyap R (2017) Functional compared to anatomical imaging in the initial evaluation of patients with suspected coronary artery disease: an international, multi-center, randomized controlled trial (IAEA-SPECT/CTA study). J Nucl Cardiol 24:507–517 - PubMed
  20. Roffi M, Patrono C, Collet J-P, Mueller C, Valgimigli M, Andreotti F, Bax JJ, Borger MA, Brotons C, Chew DP, Gencer B, Hasenfuss G, Kjeldsen K, Lancellotti P, Landmesser U, Mehilli J, Mukherjee D, Storey RF, Windecker S (2016) 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation of. Eur Heart J 37:267–315 - PubMed
  21. Amsterdam EA, Wenger NK, Brindis RG, Casey DE, Ganiats TG, Holmes DR, Jaffe AS, Jneid H, Kelly RF, Kontos MC, Levine GN, Liebson PR, Mukherjee D, Peterson ED, Sabatine MS, Smalling RW, Zieman SJ (2014) 2014 AHA/ACC Guideline for the Management of Patients With Non–ST-elevation acute coronary syndromes: executive summary. Circulation - PubMed

Publication Types